Antioxidant Pre-conditioning for Stem Cell Cartilage Regeneration

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current treatments for cartilage degeneration, such as osteoarthritis, primarily focus on pain relief and slowing disease progression, without effectively regenerating cartilage, and existing stem cell therapies face challenges in regenerative capacity and immunological responses.

Innovation Solution

Administering antioxidants and anti-inflammatory agents before, during, and after stem cell therapy, including the use of manganese-dependent superoxide dismutase gene therapy via viral vectors, mRNA liposomal delivery, or naked DNA administration, to enhance stem cell activity and modify the articular microenvironment for improved cartilage regeneration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If stem cell therapy is administered to treat cartilage degeneration, then regenerative potential is improved, but oxidative stress and inflammation reduce therapy efficacy

Engineering Contradiction:

Improvestem cell therapy efficacyVSAvoidoxidative stress and inflammation

Core Design Contradiction:

ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies preliminary action by administering antioxidants and anti-inflammatory agents before stem cell transplantation to pre-condition the articular microenvironment. This preparatory step reduces oxidative stress and inflammation in advance, creating a more favorable environment for subsequent stem cell engraftment and differentiation, thereby improving therapy efficacy without compromising the stem cells themselves

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The patent uses antioxidants and anti-inflammatory agents as intermediary substances that mediate between the harmful oxidative environment and the stem cells. These intermediaries scavenge reactive oxygen species and modulate inflammatory responses, protecting stem cells from damage while promoting their regenerative function in the articular microenvironment

Inventive Principle:

Principle #24Intermediary (Mediator)

2Stability of the object's composition

If conventional treatments focus on suppressing degeneration factors, then disease progression is slowed, but fundamental cartilage regeneration does not occur

Engineering Contradiction:

Improvedisease progression controlVSAvoidcartilage regeneration

Core Design Contradiction:

Stability of the object's compositionVSReliability

Solution Approach 1:

The patent inverts the conventional treatment approach by shifting focus from suppressing degeneration factors to actively promoting regeneration. Instead of merely slowing disease progression through anti-degenerative agents, the patent employs stem cell therapy combined with microenvironment modulation to actively regenerate cartilage tissue, fundamentally changing the therapeutic paradigm from palliative to regenerative

Inventive Principle:

Principle #13The other way round (Inversion)

3Ease of operation

If oxygen tension is increased when stem cells are taken out of hypoxic areas, then stem cells can be administered, but regenerative potential decreases

Engineering Contradiction:

Improvestem cell administrationVSAvoidregenerative potential

Core Design Contradiction:

Ease of operationVSReliability

Solution Approach 1:

The patent applies parameter changes by modifying the oxidative state of the articular microenvironment through antioxidant administration. This changes the chemical parameters (reactive oxygen species levels, oxidation-reduction potential) of the target environment, making it more compatible with stem cell regenerative function even after cells are exposed to atmospheric oxygen during administration procedures

Inventive Principle:

Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach increases the efficacy of stem cell therapy by reducing inflammation and oxidative stress, promoting a conducive environment for cartilage regeneration, potentially leading to therapeutic effects beyond pain relief and slowing disease progression.

Implementation Method 1

the gene encoding manganese dependent superoxide dismutase is administered intra-articularly

Methodology Applied

Scientific EffectSuperoxide dismutase catalysis: Enzyme

Implementation Method 2

administering at least one or more antioxidants and/or anti-inflammatory agents before, at the same time has, and subsequent to stem cell therapy

Methodology Applied

Scientific EffectRedox reactions: Redox Reactions

Data Source

PatentUS20230330193A1Enhancement of stem cell therapy for cartilage degeneration by Anti-oxidant pre-conditioning

Publication Date: 2023.10.19 CREATIVE MEDICAL TECHNOLOGIES INC

AI summary

Disclosed are means of augmenting efficacy of stem cell therapy for articular tissues through introduction of a step to reduce oxidative stress inside the joint before administration of stem cells. In one embodiment reduction of oxidative stress and/or inflammation is accomplished by administration of anti-oxidant agents locally in the tissue in which stem cell administration is anticipated to. In one embodiment administration of hydrogen gas is provided as a “preconditioning” step before administration of stem cell therapy. In one embodiment cell therapy is a same day non manipulated procedure involving administration of bone marrow aspirate.